M&T Bank’s Atara Biotherapeutics ATRA Stock Holding History

M&T Bank’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-375	Closed	-$495K	–	1826
2015 Q2	$495K	Buy	+375	New	+$430K	﹤0.01%	1215

Other funds holding ATRA

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

M&T Bank's ATRA Position: Q3 2015 in Review

M&T Bank sold out of Atara Biotherapeutics (ATRA) in Q3 2015, closing a stake of 375 shares — an estimated $495K sold.

M&T Bank first reported a position in ATRA in Q2 2015 and held it in 1 quarter. The position peaked at $495K in Q2 2015. 90 funds tracked by Wall St. Rank hold ATRA as of Q3 2015.

M&T Bank reported no remaining Atara Biotherapeutics position as of Q3 2015 after selling out during the quarter.
M&T Bank sold 375 Atara Biotherapeutics shares in Q3 2015, an estimated $495K.
M&T Bank first reported a position in Atara Biotherapeutics in Q2 2015 and held it in 1 quarter.
M&T Bank's Atara Biotherapeutics position peaked at $495K in Q2 2015.
90 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2015.

Based on M&T Bank's 13F filing for Q3 2015, filed 13 Nov 2015.